Stryker reports first quarter 2026 operating results
Stryker reported Q1 sales of $6.0 billion, up 2.6% year-over-year, while reported EPS rose 14.2% to $1.93 driven by favorable tax items and lower prior-year impairments. Underlying profitability softened as adjusted EPS declined 8.5% to $2.60 and adjusted operating margins contracted 180 basis points to 21.1%.
Key figures
- Eps
- 1.93
- Revenue
- $6.0 billion
- Guidance
- FY26 organic sales growth 8.0%-9.5%, adjusted EPS $14.90-$15.10
- Revenue Yoy
- 2.6%
- Adjusted eps
- $2.60
- Organic sales growth
- 2.4%
- Adjusted eps yoy change
- -8.5%
- Adjusted operating margin
- 21.1%
- Reported operating margin
- 15.5%
AI analysis
Red flags2 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.